Large-scale testing (Phase 3)Study completedNCT01356680What this trial is testingHD17 for Intermediate Stage Hodgkin LymphomaWho this might be right forHodgkin Lymphoma University of Cologne 1,100
Testing effectiveness (Phase 2)Study completedNCT02356159What this trial is testingStudy of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell TransplantationWho this might be right forMyelodysplastic SyndromesHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT03664635What this trial is testingMB-CART20.1 LymphomaWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaB-cell Lymphoma Refractory+1 more Miltenyi Biomedicine GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00802113What this trial is testingAutologous and Allogeneic Transplant for Relapsed LymphomaWho this might be right forNon-Hodgkin's LymphomaHodgkins Disease Columbia University 30
Testing effectiveness (Phase 2)UnknownNCT01240525What this trial is testingDonor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more University College, London 114
Not applicableEnded earlyNCT00608517What this trial is testingTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Vanderbilt-Ingram Cancer Center 6
Early research (Phase 1)Study completedNCT01611623What this trial is testingSafety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor MalignanciesWho this might be right forCancer Esanex Inc. 9
Large-scale testing (Phase 3)Study completedNCT01197560What this trial is testingStudy of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Celgene 111
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Early research (Phase 1)Study completedNCT01569750What this trial is testingA Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin LymphomaWho this might be right forCD20-positive B-cell Non-Hodgkin Lymphoma Janssen Research & Development, LLC 33
Testing effectiveness (Phase 2)UnknownNCT02134262What this trial is testingGene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesWho this might be right forRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma Jichi Medical University 18
Not applicableWithdrawnNCT05106192What this trial is testingTriamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.Who this might be right forMycosis Fungoides of Skin (Diagnosis)Cutaneous T-cell LymphomaNon Hodgkin Lymphoma+3 more Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00996593What this trial is testingStudy of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received RituximabWho this might be right forLymphoma, Non-Hodgkin GlaxoSmithKline 43
Testing effectiveness (Phase 2)Study completedNCT03770416What this trial is testingNivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System LymphomaWho this might be right forCentral Nervous System B-Cell Non-Hodgkin LymphomaRecurrent Central Nervous System LymphomaRefractory Central Nervous System Lymphoma M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT00004875What this trial is testingHeparin or Enoxaparin in Patients With CancerWho this might be right forLymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific Northwestern University 6
Testing effectiveness (Phase 2)Study completedNCT00374699What this trial is testingBortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell LymphomasWho this might be right forPeripheral T-Cell LymphomasNon-Hodgkin Lymphoma Samsung Medical Center 55
Early research (Phase 1)Looking for participantsNCT05857969What this trial is testingEx Vivo Drug Sensitivity Testing and Multi-Omics ProfilingWho this might be right forRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more Florida International University 65
Not applicableStudy completedNCT01764230What this trial is testingPrevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma PatientsWho this might be right forHodgkin LymphomaHodgkin Disease Masaryk University 72
Testing effectiveness (Phase 2)Study completedNCT03794167What this trial is testingBuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's LymphomaWho this might be right forNon-hodgkin Lymphoma Soonchunhyang University Hospital 75
Early research (Phase 1)Study completedNCT01032681What this trial is testingEMD 521873 in Advanced Solid Tumors, MTD FindingWho this might be right forNon-Hodgkin Lymphoma Merck KGaA, Darmstadt, Germany 66